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Primary squamous-cell thyroid carcinoma — a successful 
treatment with five-year follow-up
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Abstract
Squamous cell carcinoma is an extremely rare neoplasm of the thyroid (SCTC) that represents no more than 1% of all primary thyroid 
malignancies. We report a case of a 42-year-old woman with rapidly growing mass in the right lower neck, primarily diagnosed in fine-
needle aspiration cytology as a low-differentiated carcinoma. After the surgery, exclusion of all the other possible primary tumour locations, 
and immunohistochemistry tests, the diagnosis of primary squamous cell carcinoma of the thyroid gland was established. Because of close 
surgical margins and metastatic neck node, the patient was referred to adjuvant postoperative irradiation. With five-year follow-up the 
patient is free of disease and still in very good condition. (Endokrynol Pol 2017; 68 (5): 592–596)
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Streszczenie
Rak płaskonabłonkowy tarczycy jest bardzo rzadkim nowotworem złośliwym tarczycy, dotyczącym poniżej 1% rozpoznanych przypad-
ków raka tego gruczołu. W niniejszej pracy przedstawiono przypadek 42-letniej kobiety z wywiadem pod postacią szybko rosnącego 
guza prawego płata tarczycy, pierwotnie zdiagnozowanego w biopsji cienkoigłowej jako niskozróżnicowany rak tarczycy. Po zabiegu 
operacyjnym, wykluczeniu innych możliwych ognisk raka i badaniu immunohistochemicznym postawiono rozpoznanie pierwotnego, 
płaskonabłonkowego raka tarczycy. Uwzględniając obecność wąskich marginesów chirurgicznych i przerzutu do węzła chłonnego szyjnego, 
chorą zakwalifikowano do pooperacyjnej radioterapii. Po zakończonym leczeniu, od 5 lat pacjentka pozostaje w obserwacji onkologicznej 
bez cech nawrotu choroby i w bardzo dobrym stanie sprawności. (Endokrynol Pol 2017; 68 (5): 592–596)
Słowa kluczowe: rak płaskonabłonkowy tarczycy, chirurgia, radioterapia
Introduction
Squamous cell carcinoma is an extremely rare neo-
plasm of the thyroid (SCTC) that represents no more 
than 1% of all primary thyroid malignancies. Squa-
mous epithelial cells are not present in normal thyroid 
gland — only residual cells may be observed as rem-
nants of thyroglossal duct or branchial clefts. SCTC 
may arise from these cells, but also be a component 
of anaplastic or undifferentiated thyroid carcinoma. 
Some authors observed that most cases of SCTC are 
associated with tall cell variant of papillary carcinoma. 
Another possible (and the most widely accepted) 
reason for SCTC origin is squamous metaplasia of 
thyroid cells [1, 2].
The differential diagnosis of SCTC is with squamous 
cell carcinoma extending into thyroid gland from the 
hypopharynx, larynx, or oesophagus or metastasising 
from lung, nasopharynx, or other primary locations. 
Before diagnosing SCTC, other primary focuses of 
squamous cell carcinoma must be excluded [3]. 
We report a case of thyroid cancer, which was initially 
diagnosed as low-differentiated carcinoma in fine-needle 
aspiration cytology (FNAC), but final pathological exami-
nation after the surgery revealed the diagnosis of SCTC.
Case report
A 42-year-old woman with a negative thyroid gland 
malfunction observed a rapidly growing mass in the 
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right lower neck for three months. The patient visited 
a regional outpatient clinic in late September 2010, 
where diagnostic procedures were started. Cervical 
ultrasonography showed an irregular, hypoechoic 
tumour measuring 32.1 x 25.6 x 26.6 mm, located 
caudally in the right thyroid lobe and a small, ra-
diologically benign, probably colloid tumour, with 
a diameter of 7 mm, located in the left lobe. FNAC was 
performed, suggesting thyroid anaplastic carcinoma. 
The patient was immediately referred to our institute 
to confirm the diagnosis and continue the treatment. 
During physical examination a solid tumour of the 
right thyroid lobe, penetrating down to the upper 
mediastinum, was palpated. Laboratory tests showed 
normal serum concentrations of TSH, fT4, and fT3. 
Also the findings of CEA, PTH, and calcitonin were 
within normal references. FNAC was repeated and 
also revealed a low-differentiated carcinoma. Contrast-
enhanced computed tomography (CT) scan of the neck 
and thorax (November 2010) showed a soft tissue den-
sity mass arising from the inferior aspect of the right 
lobe, measuring 32 x 29 x 29 mm, adjacent to trachea 
without its infiltration (Fig. 1). No pathologies within 
the larynx, hypopharynx, and lungs with mediasti-
num and no suspicious neck nodes were diagnosed. 
Fibreoptic examination of the upper aerodigestive 
tract showed normal mucosa within the pharynx and 
larynx, without any pathologies suggesting a possible 
other primary tumour. The mobility of vocal cords 
was normal. Abdominal and pelvic ultrasonography 
showed no pathologies. The patient was planned for 
total thyroidectomy with medial neck dissection and 
biopsy of the right neck nodes. Recurrent laryngeal 
nerves and parathyroid glands were saved (November 
2010). Postoperative pathological examination re-
vealed a solid infiltration, macroscopically cream-
coloured, encompassing the majority of the right 
thyroid lobe (maximal dimension of 41 mm), but also 
going through the isthmus to the medial part of the 
left lobe. Microscopic examination showed solid sheets 
of cells widely invading the thyroid parenchyma 
with two close surgical margins. Also, one metastatic 
adjacent neck node was diagnosed. All the tumour 
cells showed squamous morphology, and positive 
immunohistochemistry staining for such squamous 
differentiation markers as CK5/6 and p40. The positive 
staining for PAX 8 confirmed the thyroid origin of the 
neoplastic cells. TTF-1 was negative. The proliferation 
index Ki-67 was 30% (Fig. 2, 3) [4].
The diagnosis of primary squamous cell carcinoma 
of the thyroid gland was given and the stage of can-
cer was evaluated as pT3pN1aM0. The patient was 
referred to the postoperative radiotherapy. Before the 
irradiation, the re-examination of the patient, based on 
fibreoptic examination and magnetic resonance imaging 
(MRI), was performed to definitely exclude a possible 
primary tumour within the aero-digestive tract — no 
pathologies were found. Postoperative radiotherapy 
was performed between February 2, 2011 and March 
12, 2011, with the intensity-modulated radiotherapy 
technique (IMRT). A total dose 60 Gy in 30 fractions 
(2 Gy) within the thyroid bed and adjacent metastatic 
neck lymph node bed and a dose of 50 Gy in 25 fractions 
(2 Gy) were given for bilateral lymph nodes groups 
(II, III, IV, VI, and upper mediastinum). The tolerance 
of radiotherapy was good — spotted and confluent 
mucositis was observed with no more than 50% of the 
irradiated mucosa within the hypopharynx and larynx. 
Figure 1. Contrast-enhanced computed tomography scans of the neck, showing soft tissue density mass arising from the inferior aspect 
of the right lobe adjacent to the trachea
Rycina 1. Obrazy tomografii komputerowej z kontrastem szyi w trzech projekcjach ukazujące miękkotkankową masę wyrastającą 
z dolnej części prawego płata tarczycy, przylegającą do tchawicy
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To date, the patient has survived 60 months following 
radiotherapy, with no evidence of recurrence.
Discussion
Primary SCTC is an uncommon cancer of the thyroid 
gland. The incidence of pure SCTC in the English- 
-language literature ranges from 0.2% to 1.1% of all 
neoplasms of the thyroid [5]. It usually occurs in the 
5th to 7th decades of life with a mean age at diagnosis 
of 65 years (range 24–90 years) and female prevalence 
(female-to-male ratio 2:1) [5, 6]. Primary SCTC may 
coexist with papillary and anaplastic thyroid cancer. 
Pure SCTC, occurring solitarily without other tumours, 
is extremely rare. Although controversial, squamous 
metaplasia is the most widely accepted aetiological 
theory of primary SCTC [1, 2, 7]. 
Patients with SCTC routinely present with rapidly 
growing neck mass and swelling. Based on the clinical 
symptoms, it is nearly impossible to distinguish SCTC 
from anaplastic cancer [7]. Predictability of diagnosis of 
SCTC with fine-needle aspiration biopsy is accurate in 
less than one-third of patients [1, 2, 6, 8–11]. As the disease 
progresses, dysphagia and hoarseness may occur [9]. 
SCTC is an aggressive, highly lethal neoplasm [7]. Me-
tastases from primary SCTC are common, especially 
Figure 2A. Squamous carcinoma infiltrating the thyroid parenchyma. Note the abundant lymphocytic infiltration (B); C. Cytokeratin 
5/6 extensively positive in tumour cells*; D. p 40 positive in tumour cells, negative in the accompanying lymphocytes*; E. TTF-1 
positive in thyroid parenchyma, negative in the tumour; F. Ki 67 proliferation index
*IHC Markers of squamous differentiation
Rycina 2A. Rak płaskonabłonkowy naciekający miąższ tarczycy. Zauważalny obfity naciek limfocytarny (B); C. Intensywnie dodatnia 
cytokeratyna 5/6 w komórkach raka; D. Dodatnia reakcja markera p40 w komórkach raka, ujemna w sąsiadujących limfocytach; 
E. Dodatnia reakcja markera TTF-1 w miąższu tarczycy, ujemna w komórkach raka; F. Marker proliferacji Ki-67
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to cervical lymph nodes (35%), but may occur in lungs, 
bones, liver, kidney, and heart [2, 5, 11].
Local relapse and progression to larynx and trachea 
causing dyspnoea and respiratory obstruction are the 
main reasons of treatment failure and death [7, 10, 12, 13]. 
Occasionally, cancer dissemination with pulmonary 
metastases may lead to death.
Because of the rarity of this disease, there are no 
standardised guidelines for the treatment of primary 
SCTC. Treatment modalities include surgical resection, 
which is the procedure of choice. However, operation 
alone is not a sufficient treatment for these cancers 
because of the high risk of tumour relapse. Although 
SCTC is regarded as relatively radio-resistant, adjuvant 
radiotherapy (50–66 Gy in 25–33 fractions, the dose de-
pends on risk factors) should be a standard procedure. 
Chemotherapy has not been shown to be beneficial 
in SCTC [2, 12, 14], but in cases of positive surgical 
margins and pericapsular infiltration, postoperative 
radiotherapy combined with cisplatin, as in advanced 
head and neck squamous cell cancer, may be justified. 
To date, no sufficient information is available on its use 
in SCTC. If possible, debulking procedures with trachea 
reconstruction may be carried out in patients with 
advanced local disease to avoid suffocation caused by 
obstruction or bleeding [1, 2]. When radical surgery in 
advanced cases is not possible, palliative radiotherapy 
(20 Gy in five fractions or 30 Gy in 10 fractions) may be 
beneficial to improve quality of life [15]. 
Prognosis of SCTC is very poor and the majority 
of patients die within one year after the diagnosis (the 
median survival is nine months; three-year survival 
is only 20%) [6, 7, 12]. Treatment should primarily be 
concentrated on surgical resection with negative mar-
gins. Complete surgical resection (R0) was the only 
significant prognostic factor in multivariable analysis 
[6, 14]. Although the benefit of adjuvant treatment was 
not proven, the results reported in the literature showed 
that patients with complete excision and postoperative 
radiotherapy had better survival when compared to 
patients with complete excision alone or incomplete 
excision with radiotherapy [2, 5, 13, 14, 16]. The presence 
of lymph node metastasis is also an important negative 
prognostic factor. Mean overall survival of patients 
with lymph node metastasis is shorter compared with 
patients without metastasis (10.8 vs. 16.4 months) [5]. 
We report a case of a female patient with primary 
SCTC treated with surgery and adjuvant radiation 
therapy with long, five-year follow-up without relapse. 
In our case, two close margins and one metastatic neck 
node were found, so adjuvant treatment was manda-
tory. Because of the lack of evidence of efficacy of 
Figure 3. Positive reaction of PAX 8, the sensitive marker for thyroid origin in tumour cells, as well as in the thyroid follicles
Rycina 3. Dodatnia reakcja PAX 8, czułego markera pochodzenia tarczycowego komórek nowotworu, obecna w komórkach raka 
płaskonabłonkowego i komórkach pęcherzyków tarczycy
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concurrent postoperative radio-chemotherapy in SCTC, 
we performed radiotherapy alone to an elective dose 
within neck nodes and escalated dose for the thyroid 
bed and metastatic lymph node bed. The long follow-up 
in our case shows that there is a possibility of successful 
treatment and cure in some patients with SCTC.
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